Txoj Kev Siv thiab Txoj Kev: Kev sib koom tes, kev sib haum xeeb thiab yeej-yeej
cov khoom

Cov khoom

Solifenacin Succinate CAS: 242478-38-2 Chaw tsim tshuaj paus

Solifenacin succinate yog ib qho tshuaj antimuscarinic uas yog siv los kho lub zais zis ntau dhau ua rau cov tsos mob ntawm zaus, ceev, lossis incontinence.Solifenacin yog M3 muscarinic receptor antagonist uas tau tsim thiab tsim los kho cov zais zis ntau dhau (pollakiuria) hauv Tebchaws Europe.M3 receptors tau cuam tshuam rau hauv neurally evoked du leeg nqaij contractions ntawm lub zais zis, thiab M2 receptors kuj tau xav tias ua si lub luag hauj lwm vim hais tias ntawm lawv dominance nyob rau hauv lub detrusor nqaij.


Product Detail

Khoom cim npe

Kev siv thiab cuam tshuam

Solifenacin succinate yog urinary antispasmodic ntawm cov chav kawm antimuscarinic. Cov kev mob tshwm sim uas xav tau nrog cov tshuaj no thiab tsis tas yuav kho mob tshwj tsis yog lawv txuas ntxiv los yog thab plaub: qhov ncauj qhuav;qhov muag qhuav;cem quav, qhov muag tsis pom kev, tso zis nyuaj.Cov tshuaj no, zoo li txhua yam tshuaj anticholinergic, tuaj yeem ua rau lub qhov ncauj qhuav.Txij li thaum lub qhov ncauj qhuav txuas ntxiv tuaj yeem ua rau muaj kev pheej hmoo ntawm cov hniav, ceeb toom koj tus kws kho hniav yog tias koj noj cov tshuaj no.Solifenacin tau tawm hauv cov quav uas tsuas yog 3-6% pom hauv cov zis.Nws yog contraindicated nyob rau hauv cov neeg mob uas muaj hepatic impairment, gastric retention, tso zis, los yog uncontrolled nqaim lub glaucoma.

Khoom qauv

kev 6
xoj 7

Cov khoom ntim:

kev 33

Cov ntaub ntawv ntxiv:

Kev sib xyaw C27H32N2O6
Assay 99%
Qhov tshwm sim Dawb rau Off-White hmoov
CAS Nr. 242478-38-2
Ntim 25 KG
Txee lub neej 2 xyoo
Cia Khaws rau hauv qhov chaw txias thiab qhuav
Daim ntawv pov thawj ISO.

  • Yav dhau los:
  • Tom ntej:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb